Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of Endostar combined with concurrent chemoradiotherapy for advanced esophageal cancer
ChiCTR2000030111Phase 2Recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of endostar in esophageal cancer, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoint: Recent efficacy. Started Sep 2019; status: recruiting.
02
Drugs
endostar
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on ChiCTR2000030111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030111.